Latest / Pharmacy Podcast Network / The Power of Personalized Medication Management | Direct Access Podcast; ComputerTalk
Transcript
- 0:05Speaker 1: You are listening to the global network of podcasters dedicated
- 0:08Speaker 1: to the pharmacy profession. Welcome to the Pharmacy podcast Network.
- 0:27Speaker 2: Hi, it's Maggie Lockwood and welcome to Pharmacy Technology and
- 0:29Speaker 2: Management Reviews Direct Access Interview Series. Today we welcome Madshaw,
- 0:34Speaker 2: CEO of Claire's Health. He's a pharmacist with a variety
- 0:37Speaker 2: of experience in the pharmacy industry, and he talks about
- 0:41Speaker 2: Claire's Health mission to deliver high quality, personalized medication management
- 0:45Speaker 2: to patients in long term care settings. We talk about
- 0:48Speaker 2: how Claire's Health goes beyond traditional pharmacy models. They focus
- 0:52Speaker 2: on risktrafication, identifying patients most likely to benefit from personalized
- 0:57Speaker 2: care due to medication adherance challenges, advert complex medication regiments,
- 1:03Speaker 2: patient engagement, and how collaborating with patients and their physicians
- 1:06Speaker 2: develop a holistic plan can address medication needs and goals
- 1:10Speaker 2: and evidence based guidelines. How Claris uses algorithms and clinical
- 1:14Speaker 2: expertise to ensure medication therapy is optimized in aligns with
- 1:18Speaker 2: best practices. Hope you enjoy the interview.
- 1:23Speaker 3: So my name is Hamadsha. I'm a pharmacists by degree.
- 1:26Speaker 3: I grew up in Philadelphia, went to Temple University Pharmacy School,
- 1:32Speaker 3: and have spent most of my career in pharmacy. Spent
- 1:37Speaker 3: the first decade of my career running retail drug stores,
- 1:41Speaker 3: then was in the PBM industry for about a decade,
- 1:45Speaker 3: and the third decade has really been more in private
- 1:48Speaker 3: equity backed organizations, but most of the time focused in
- 1:54Speaker 3: and around pharmacy. I think with that experience that I have,
- 1:59Speaker 3: I didn't just pharmacy from one angle. I've seen it
- 2:02Speaker 3: from multiple angles. So hopefully it gives me greater knowledge
- 2:06Speaker 3: about the space. And you wanted to ask about.
- 2:10Speaker 2: Pro care, Sorry, go ahead, Well this is actually just interesting.
- 2:14Speaker 2: So I live in Philadelphia, We're in Bluebell, Okay, So
- 2:18Speaker 2: thank you for sharing us, giving me a little in
- 2:20Speaker 2: your background. And I guess let's just jump into understanding
- 2:25Speaker 2: more about cleric and the clinical programs and how you
- 2:29Speaker 2: aim to address the highest risk members. And I know
- 2:33Speaker 2: I'm curious what that looks like. What when you say
- 2:35Speaker 2: highest risk members, what does that that mean? And how
- 2:40Speaker 2: does this differ from traditional models pharmacy model.
- 2:44Speaker 3: Well, look, I think the traditional pharmacy models are more
- 2:48Speaker 3: somebody's got a prescription. Let me fill that prescription, let
- 2:51Speaker 3: me make sure it's accurate, and let me get it
- 2:53Speaker 3: to them. We work in many different ways and we
- 2:57Speaker 3: have different tentacles in the organization. So one of the
- 3:01Speaker 3: things that we do is work with pair organizations to
- 3:04Speaker 3: take their patient population and risk stratify it and say,
- 3:08Speaker 3: who are the members that are really we think not
- 3:11Speaker 3: adherent to their meds or have challenges in terms of
- 3:16Speaker 3: adverse events or vice events related to med therapy, maybe
- 3:20Speaker 3: aren't on the right meds altogether because they've got four
- 3:24Speaker 3: different positions are seeing and we going to three different
- 3:27Speaker 3: pharmacies to try to get the price best price on meds,
- 3:30Speaker 3: and somewhere in the mix there they're really not in
- 3:33Speaker 3: optimal therapy. So we are not in the business of
- 3:37Speaker 3: just sending meds to the patient home and saying our
- 3:40Speaker 3: job's done. We're having them pick it up at retail
- 3:43Speaker 3: and say any questions, none, good, you're on your own now.
- 3:47Speaker 3: We really want to be engaged with that patient to
- 3:51Speaker 3: make sure again write therapy, you know, write set of
- 3:55Speaker 3: drugs and compliance at adherents. And we have other programs also.
- 3:59Speaker 3: But you asked how we differentiate and I think that
- 4:03Speaker 3: that care, that that engagement with that patient to ensure
- 4:08Speaker 3: the right therapy and not just the patient but their
- 4:10Speaker 3: provider also, so we go that extra mile to make
- 4:13Speaker 3: sure those things are done well.
- 4:16Speaker 2: I think that this idea of personalized care is what
- 4:19Speaker 2: you're talking about here. And I guess you know, when
- 4:24Speaker 2: you talk about personalized care planning, which I think is interesting,
- 4:28Speaker 2: you know, you're talking about working with the patient and
- 4:32Speaker 2: also working with the physician and that you know a
- 4:36Speaker 2: lot of times that comes up as like collaborative care,
- 4:41Speaker 2: And I guess what are the as you see at
- 4:43Speaker 2: the impact that has in improving quality of life for
- 4:48Speaker 2: the patient and outcomes as well being able to keep
- 4:52Speaker 2: everyone on the same page in that way and looking
- 4:54Speaker 2: at specifically at that patient and their issues that might
- 4:59Speaker 2: come up from their lack of accurance or yeah, I
- 5:03Speaker 2: guess lack of adherance would be the main example here.
- 5:07Speaker 3: Let's start with the personalized care planning and how it starts.
- 5:11Speaker 3: So we get pharmacy claims and again we get them
- 5:14Speaker 3: from the pair, right, we get the medical diagnosis, and
- 5:18Speaker 3: then we interview that patient and we really jump into
- 5:22Speaker 3: the details to validate the things that we've seen in
- 5:25Speaker 3: the claims data. Sometimes it's not accurate.
- 5:28Speaker 2: Right.
- 5:29Speaker 3: Sometimes patients are getting cash meds from places and it's
- 5:32Speaker 3: not showing up anywhere. In addition to that, there might
- 5:35Speaker 3: be ATC meds that they're taking and they don't show
- 5:39Speaker 3: up anywhere, and even in the physicians data and the
- 5:42Speaker 3: EMRs don't show up because the patient forgets. And then
- 5:45Speaker 3: when we take that information, we set up we have
- 5:49Speaker 3: algorithms set up in our system and they look at
- 5:52Speaker 3: medication related problems that we may identify and rank them
- 5:57Speaker 3: highest to say, okay, well, look these are glaring things
- 6:01Speaker 3: that we're seeing in terms of met therapy that need
- 6:04Speaker 3: to be addressed with a patient. So our caregivers have
- 6:09Speaker 3: that information in front of them before they do the
- 6:12Speaker 3: interview process. In the interview process, we also intermingle the
- 6:16Speaker 3: goals that the patient may have. We try to find
- 6:19Speaker 3: out a little bit more about that patient. Are they
- 6:21Speaker 3: having challenges, do they have certain priorities in their care
- 6:25Speaker 3: plan that we can incorporate in And once we've got
- 6:29Speaker 3: all of that done, we've got a holistic plan that
- 6:32Speaker 3: now we can reach out to the different providers that
- 6:35Speaker 3: they have if there's adjustments in therapy needed, and how
- 6:39Speaker 3: we see this manifest itself is that the patient feels
- 6:43Speaker 3: that they're part of that plan, and when they're a
- 6:45Speaker 3: part of it and they've got ownership in it, they're
- 6:48Speaker 3: more likely to be adherent to that plan. In addition,
- 6:52Speaker 3: what we see and we've seen this in data, is
- 6:55Speaker 3: fewer hospitalizations and fewer visits. Right, the physician can only
- 7:00Speaker 3: do so much in an acute setting when you go
- 7:03Speaker 3: visit a once every six months, once every quarter. If
- 7:06Speaker 3: you're not taking the meds properly, and if the fundamentals
- 7:10Speaker 3: aren't right, there's nothing that the physician can do for you. Right,
- 7:14Speaker 3: So we really focus on those care needs. And what
- 7:16Speaker 3: we've seen is a reduction in cost because if there's
- 7:20Speaker 3: less entry into the hospital, there will be a reduction
- 7:23Speaker 3: in costs. If they're less acute procedures or things that
- 7:26Speaker 3: need to be done because therapy wasn't right, there'll be
- 7:29Speaker 3: a reduction in cost, and the patient feels better. So
- 7:34Speaker 3: those are the things that we think really matter in
- 7:37Speaker 3: terms of outcomes.
- 7:39Speaker 2: And the kind of patient you're talking about is a
- 7:42Speaker 2: patient of multiple meds RAT. We're talking about patients multiple
- 7:46Speaker 2: meds or with a complex health issue that is not
- 7:54Speaker 2: easily managed by once you know, twice a year visit
- 7:58Speaker 2: to a doctor. This is an ongoing health management issue
- 8:02Speaker 2: for this patient.
- 8:04Speaker 3: You're absolutely right. Look, you know, I put patients into
- 8:10Speaker 3: the spectrum. That's how I view them. Right, they're all
- 8:13Speaker 3: the way on the left or folks that you know
- 8:15Speaker 3: are relatively healthy. They're maybe taking a MET or two,
- 8:18Speaker 3: maybe taking cholesterol med but there's not much we can
- 8:21Speaker 3: do there. I mean, they've just got to take their
- 8:23Speaker 3: MET every day and that's that. Right in the middle
- 8:25Speaker 3: is a general population where there are some issues, but
- 8:29Speaker 3: overall they're pretty well contained and we don't see an
- 8:32Speaker 3: opportunity for intervention that will yield a real benefit either
- 8:37Speaker 3: to the patient or to the pair. Then you think
- 8:41Speaker 3: on the right hand side of the spectrum, and these
- 8:43Speaker 3: are the patients that are constantly in and out of
- 8:46Speaker 3: hospitals where it's not just hospitals. Think of it as
- 8:50Speaker 3: the coordination of care and a post acute setting. Right,
- 8:53Speaker 3: they may go to a hospital, then they may go
- 8:55Speaker 3: to a skilled nursing facility to recover and to rehab
- 8:57Speaker 3: for a bit. Then they may go home and they
- 9:00Speaker 3: may transition again. It's this constant rotation which is increasing costs,
- 9:06Speaker 3: but it's also really impacting very negatively the health of
- 9:10Speaker 3: that patient. They can't get settled anywhere, they're constantly transitioning,
- 9:15Speaker 3: and it's a big burden for them. Right, So we
- 9:18Speaker 3: really look at all of these things that are impacting
- 9:22Speaker 3: the patient. We look at that patient and the bottom
- 9:24Speaker 3: right of the spectrum as I defined it, these folks
- 9:28Speaker 3: may be on six to eight different medications, they may
- 9:31Speaker 3: have three to four different come morbidities. They may be
- 9:35Speaker 3: visiting a neurologist, a nephrologists, a cardiologist. And as we know,
- 9:41Speaker 3: those physicians, as great as they are, they're great in
- 9:44Speaker 3: their space.
- 9:44Speaker 2: Right, they don't talk to each other.
- 9:46Speaker 3: They don't they don't and their records don't interact. There
- 9:51Speaker 3: isn't someone that is an advocate for that patient other
- 9:57Speaker 3: than caregivers. And if you look at the care givers,
- 10:00Speaker 3: you know it's if it's a son or daughter, if
- 10:02Speaker 3: it's a husband or wife, many times their healthcare literacy
- 10:06Speaker 3: isn't to the point where they can really question. So
- 10:09Speaker 3: that's where we step in and we think this type
- 10:12Speaker 3: of service is critical you know in society today and
- 10:18Speaker 3: we all know based on information that we've seen that
- 10:22Speaker 3: it's that right of the spectrum. It's those few patients
- 10:25Speaker 3: that are really the ones that need this help.
- 10:30Speaker 2: They're the ones when they talk about and I don't
- 10:33Speaker 2: want throughout statistics because I can't, I'd have to look
- 10:37Speaker 2: it up, but those are the ones that are the
- 10:38Speaker 2: highest costs.
- 10:41Speaker 3: Yes, they're the most.
- 10:42Speaker 2: Extensive patients, and so not only can you help them,
- 10:49Speaker 2: you know, clinically, but then you can also help financially
- 10:53Speaker 2: because if you're saying you don't have these these lapses
- 10:57Speaker 2: in care or duplications of care, by tracking and having
- 11:05Speaker 2: all the information in one place, you're going to everyone's
- 11:09Speaker 2: going to benefit. The system benefits, the healthcare system benefits,
- 11:11Speaker 2: but the patient benefits as well. So it's it helps
- 11:15Speaker 2: in multiple ways. And I guess that's interesting because one
- 11:18Speaker 2: of the questions here that I wanted to ask, and
- 11:21Speaker 2: I'm curious about this, when you talk about this evidence
- 11:23Speaker 2: based guidelines for the clinical programs, I feel like that's
- 11:26Speaker 2: kind of what you're talking about here, right, this idea
- 11:28Speaker 2: that you're looking at all this data and you're able
- 11:30Speaker 2: to develop programs that will help help the patients.
- 11:38Speaker 3: I absolutely agree. So I think the fundamental basis is
- 11:41Speaker 3: the evidence based guidelines. There's a lot of literature out there.
- 11:45Speaker 3: It's it's difficult because it's changing. There's more information coming
- 11:50Speaker 3: out all the time. And we have folks that are
- 11:53Speaker 3: clinicians whose job it is from parting tonight to really
- 11:58Speaker 3: be monitoring and managing the information that's coming out on
- 12:01Speaker 3: therapy and on medication management. And they take this information
- 12:07Speaker 3: and embed it into the framework into the algorithms that
- 12:10Speaker 3: we have. So the core this is evidence based management, right,
- 12:15Speaker 3: and and those guidelines are critical to what we do.
- 12:19Speaker 3: So absolutely agre.
- 12:23Speaker 2: And how how did you you know as you develop
- 12:27Speaker 2: that as from a company standpoint, when you when you
- 12:30Speaker 2: see there's a need here, I guess what's the background, Like,
- 12:34Speaker 2: what's the background that goes into deciding that's the way
- 12:36Speaker 2: to go with this? That you want to look as
- 12:39Speaker 2: much data as possible and you know, hire experts like
- 12:43Speaker 2: you're saying, like pharmacists and clinical experts. You can then
- 12:47Speaker 2: evaluate it in an effective way and then I assume
- 12:50Speaker 2: using AI and other technology to process it to create
- 12:55Speaker 2: the framework that you you're able to implement.
- 13:00Speaker 3: Yeah, look, I think you know when we started this.
- 13:04Speaker 3: I think you asked this earlier, and you know, how
- 13:06Speaker 3: did this begin? And how do we get to where
- 13:07Speaker 3: we are today. We started this with a couple of
- 13:11Speaker 3: institutional pharmacies and we really took care of those patients
- 13:14Speaker 3: that were in nursing homes and skilled care facilities right
- 13:19Speaker 3: still nursing facilities. Over time, we saw these opportunities to say, look,
- 13:25Speaker 3: there's just a lot of patients here that are coming
- 13:26Speaker 3: in and out, and if we just hire pharmacists to
- 13:30Speaker 3: sit there and constantly be looking through information and paypalwork
- 13:35Speaker 3: and data, it's really not a great use of that
- 13:37Speaker 3: pharmacist time. A lot of the stuff needs to be
- 13:40Speaker 3: standardized in some software with some algorithms, and based on
- 13:45Speaker 3: that pharmacist knowledge and the clinical and evidence based guidelines,
- 13:50Speaker 3: things should be highlighted for them. Right, these are the
- 13:53Speaker 3: things that we need to focus on based on the
- 13:55Speaker 3: information that we entered into the system. That's what we've done.
- 13:58Speaker 3: So we needed that keep ability. So we went and
- 14:02Speaker 3: purchased that capability in a form of a company that
- 14:05Speaker 3: had software that was still in its infancy. Needed a
- 14:09Speaker 3: lot of work, but we acquired it because we had
- 14:11Speaker 3: a foundation, and then with our clinical teams, we started
- 14:15Speaker 3: to build that up. We started to build up the
- 14:18Speaker 3: algorithms to make them robust. So we did look at
- 14:21Speaker 3: these as capabilities. Then we acquired another organization that had
- 14:27Speaker 3: patients that they serviced at home. So they had a
- 14:31Speaker 3: patient population that lived at home, and it was a
- 14:33Speaker 3: small organization, but they served as those advocates that I described, right.
- 14:38Speaker 3: They engaged with the patient on a regular basis, how
- 14:41Speaker 3: are you doing, what's going on, how's your therapy? And
- 14:45Speaker 3: it was also a pharmacy that sent meds to that patient,
- 14:49Speaker 3: so it had the whole wrap around. Not only will
- 14:52Speaker 3: we be your advocate, make sure you're on the right meds,
- 14:55Speaker 3: speak to your doctor, make sure adjustments are necessary, will
- 14:58Speaker 3: do them, but we will also be your pharmacy of
- 15:02Speaker 3: record and send the mets to you. Then we combine
- 15:05Speaker 3: these capabilities, right, So where the second company that I
- 15:09Speaker 3: described that was sending them meds, they were doing a
- 15:12Speaker 3: pharmacist manually. You don't have to now we got the software,
- 15:17Speaker 3: so we put it together. So over time it's been
- 15:21Speaker 3: going after certain capabilities that we think are critical to
- 15:25Speaker 3: really scale, and then we acquire those capabilities and put
- 15:29Speaker 3: them into one That's really how this has evolved.
- 15:32Speaker 2: Well it's so interesting too because the pharmacists, I mean
- 15:37Speaker 2: from a slightly different take on this. I mean, the
- 15:39Speaker 2: number of pharmacists I've talked to who still use paper
- 15:43Speaker 2: to manage their MTM. They have a paper calendar or
- 15:47Speaker 2: and yet their system. You're describing a system here where
- 15:50Speaker 2: they don't have to do that, right, This is going
- 15:52Speaker 2: to be presented for them and they're then able to
- 15:55Speaker 2: make use their expertise to make clinical decisions as opposed
- 15:59Speaker 2: to opening a binder with and alphabetically and going and
- 16:04Speaker 2: buying the patient and then crossing a calendar or something.
- 16:08Speaker 2: I mean, I think that's the point of this technology
- 16:11Speaker 2: and pharmacy is to get away from these manual processes.
- 16:15Speaker 2: I mean there's just not enough time. And when you
- 16:17Speaker 2: talk about patients that you're talking about there are high risk.
- 16:20Speaker 2: I mean, you need all that information right there for
- 16:23Speaker 2: you to review.
- 16:25Speaker 3: I'll give you one other piece. I absolutely agree with
- 16:28Speaker 3: everything you said. The other piece I'll tell you is
- 16:31Speaker 3: just in terms of labor you're talking efficiency and productivity.
- 16:36Speaker 3: Imagine how many pharmacists you have to hire as this
- 16:39Speaker 3: population is aging, right, the baby boomers are aging. There
- 16:43Speaker 3: are so many people that need this kind of care.
- 16:46Speaker 3: If we have the same old manual methods, and paper
- 16:48Speaker 3: based methods. You'd be hiring rooms and rooms full of
- 16:52Speaker 3: pharmacists shifting through paperwork, and I'm not sure you could
- 16:56Speaker 3: find enough pharmacist to be able to do all of
- 16:58Speaker 3: that you did. Let's say you found them, right, and
- 17:02Speaker 3: they're willing to work for you and willing to do
- 17:04Speaker 3: all of this. Well, how do you get pharmacist A
- 17:07Speaker 3: and pharmacist D to do the same exact thing if
- 17:12Speaker 3: you're going to use their judgment and paper Because you
- 17:14Speaker 3: may have one pharmacist that looked at it and say,
- 17:17Speaker 3: you know, in my view, this is how we should
- 17:20Speaker 3: address the therapy need. And somebody could have some other
- 17:23Speaker 3: way of doing it, and it may you never know,
- 17:27Speaker 3: they might not be following the standard evidence based guidelines.
- 17:32Speaker 3: If you have it in a software and you have
- 17:34Speaker 3: it embedded that way and the algorithms are built that way,
- 17:37Speaker 3: and the output has really come out. Now you're giving
- 17:40Speaker 3: the pharmacists specific action items and you know on the
- 17:43Speaker 3: back end it's standardized. So the quality and the level
- 17:47Speaker 3: of care that each patient is receiving is equal. Right,
- 17:51Speaker 3: It's not variable dependent upon if the person slept through
- 17:55Speaker 3: biocam or medicinal cam that day, Right, the pharmacist did,
- 17:59Speaker 3: so it's standard. Obviously I'm joking, but you understand what
- 18:03Speaker 3: I mean.
- 18:04Speaker 2: I think it's really interesting also because I mean one
- 18:06Speaker 2: of the topics we were going to talk about was
- 18:08Speaker 2: the impact on healthcare costs, and I think that what
- 18:12Speaker 2: you're talking about, which is standard care, not variable care
- 18:19Speaker 2: based on the farm. Because also, you know, the reality
- 18:22Speaker 2: is we were sort of joking about it, but there's
- 18:25Speaker 2: not the same pharmacist in the pharmacy every day either,
- 18:28Speaker 2: nor if you have a patient and skilled or you know,
- 18:31Speaker 2: in a facility, if you're closed door, or or you're
- 18:34Speaker 2: doing long term care at home and you're delivering the
- 18:38Speaker 2: homedown patient, you're not the same people are not involved
- 18:42Speaker 2: all the time. So when you have this consistent care
- 18:46Speaker 2: being provided, then that's going to reduce health care costs
- 18:51Speaker 2: because you're not going to have like you're talking about labor,
- 18:54Speaker 2: You're not going to talk about mistakes and packaging being returned.
- 18:58Speaker 2: They're all these different ways it's going to reduce health
- 19:02Speaker 2: care costs.
- 19:04Speaker 3: Yeah, absolutely, I agree, But look, I break it down
- 19:06Speaker 3: in terms of the impact on healthcare costs. There's three
- 19:09Speaker 3: big buckets that I think about right. One is We
- 19:12Speaker 3: talked about it before the adherence bucket many people, including
- 19:17Speaker 3: a lot of retail pharmacies, where again people can tell me,
- 19:20Speaker 3: I don't know what I'm talking about, but I worked
- 19:22Speaker 3: a decade in that space. They measure adherence by did
- 19:28Speaker 3: you pick up your med mereth if you picked up
- 19:30Speaker 3: your meds, there you go. You're adherent. You're coming every month,
- 19:33Speaker 3: you're picking up your meds. Right. But I've worked in
- 19:38Speaker 3: you know, I worked for an organization that did dialysis
- 19:42Speaker 3: care and I started their pharmacy for them, and we
- 19:44Speaker 3: sent people into those patients' homes and they opened up
- 19:48Speaker 3: the cabinets and yes, they were getting meds every month,
- 19:51Speaker 3: but the cabinets are full of the medications, they're not
- 19:54Speaker 3: taking them. So who measures that? Who is there to
- 19:59Speaker 3: really truly measure compliance in adherence with the medication therapy.
- 20:04Speaker 3: We do that, and we have ways and we have
- 20:07Speaker 3: tricks to really understand if the drugs are being taken right,
- 20:11Speaker 3: and we are not just worried about dispensing and saying
- 20:15Speaker 3: our job is done. So I think the impact of
- 20:20Speaker 3: medication adherence is a straight line to the healthcare cost. Right.
- 20:25Speaker 3: That's one thing that you got to get down. Then
- 20:27Speaker 3: there is the efficiency of the drug therapy. We have
- 20:32Speaker 3: found people that we've talked to and when we've done
- 20:34Speaker 3: these interviews, we have found things that were undiagnosed that
- 20:39Speaker 3: needed therapy. We found gaps in medication therapy. We found
- 20:44Speaker 3: overlap drugs and medication therapy. Right. So the lack of
- 20:49Speaker 3: an effective therapy is creating issues and creating cost in
- 20:55Speaker 3: the system that we can take out. And it's not
- 20:58Speaker 3: necessarily we have to think broader here. It's not just
- 21:01Speaker 3: the old method of Oh, they were on ten medications.
- 21:04Speaker 3: I looked at it, I reduced it to eight. Look
- 21:06Speaker 3: how much money I saved with the two meds and
- 21:08Speaker 3: not taking Now we're not looking at that short term
- 21:12Speaker 3: tactical benefit. What we're looking at is a therapy, right,
- 21:16Speaker 3: because we firmly believe if the therapy is right, the
- 21:20Speaker 3: larger healthcare cost will be reduced because of lack of
- 21:24Speaker 3: re entry into a hospital and better outcomes for that patient.
- 21:29Speaker 3: And the third piece we really look at, which is
- 21:31Speaker 3: the third big bucket, right, is adverse events. And there's
- 21:35Speaker 3: all kinds of statistics out there that you can research,
- 21:38Speaker 3: but some say twenty five percent of the patients that
- 21:41Speaker 3: re entry into the hospital, re enter because of a
- 21:44Speaker 3: med related event. Right when they leave a hospital, they
- 21:47Speaker 3: go home, they're taking a whole you know, different therapy,
- 21:52Speaker 3: a lot of different medications, something interacts, they're back in again. Right,
- 21:57Speaker 3: How can we prevent that because that entry in the
- 22:00Speaker 3: hospital is very costly, not financially, not just financially, let's
- 22:05Speaker 3: say it that way, which is how maybe the payers
- 22:08Speaker 3: look at it. It's tough with that patient. If you
- 22:12Speaker 3: take an eighty or ninety year old patient, take them
- 22:15Speaker 3: from their home and have to put them back in
- 22:18Speaker 3: a hospital for a stay, their health deteriorates during that
- 22:24Speaker 3: period of time. So those are the three big buckets
- 22:29Speaker 3: that we focus on. Now, there's a lot of sub
- 22:32Speaker 3: bullets down there in terms of things that we do.
- 22:34Speaker 3: But if you can get those three big things right,
- 22:37Speaker 3: you're headed in the right direction.
- 22:40Speaker 2: Right, right, How do you find how does the software
- 22:43Speaker 2: work for closing the loops so to speak? So how
- 22:47Speaker 2: do you you know, you talk a lot about interviewing,
- 22:50Speaker 2: so you are constantly talking to the patients and then
- 22:54Speaker 2: putting their responses into you know, and putting that data,
- 22:59Speaker 2: and then that's obviously going into creating the helping the
- 23:05Speaker 2: algorithm continue to make evaluate the data overall for the
- 23:09Speaker 2: medications and the medication therapy management. How does that happen?
- 23:14Speaker 2: How do you find I guess it's the equivalent of
- 23:17Speaker 2: bidirectional information, right, this is coming from outside the system
- 23:20Speaker 2: and going into the system.
- 23:23Speaker 3: Well, look, the system, as I told you before, starts
- 23:25Speaker 3: with a set of core data, whereas pharmacy claims, lack
- 23:28Speaker 3: of claims, medical diagnosis, all of that stuff. And then
- 23:32Speaker 3: you're right, we have inputs, which are the patient information.
- 23:37Speaker 3: Once all that is in there, the algorithm churns and
- 23:40Speaker 3: highlights key areas that we should really be focused on. Now. Subsequently,
- 23:45Speaker 3: touches with that patient provide additional information. And when that
- 23:49Speaker 3: additional information comes in, there's a reprioritization. Does something need
- 23:54Speaker 3: to change? Are we still headed in the right direction?
- 23:57Speaker 3: And that constant reprioritization is really what's beneficial Now. The
- 24:02Speaker 3: reprioritization is also based on the evidence based guidelines. Let's
- 24:06Speaker 3: say there's new literature that came out during the period
- 24:08Speaker 3: of time since these last touch Now that is embedded
- 24:12Speaker 3: in and now the algorithms are turning based on new information.
- 24:16Speaker 3: So if there's adjustments that need to be made. Now
- 24:19Speaker 3: the pharmacist is more aware, or the caregiver whoever it
- 24:22Speaker 3: is that's interacting with that patient is more aware because
- 24:26Speaker 3: it's highlighted for them the things that they need to
- 24:29Speaker 3: address with that patient. So software is critical. I mean,
- 24:33Speaker 3: you know, I used to be a pretty good pharmacist.
- 24:36Speaker 3: There's no way I could keep all this straight. It's
- 24:39Speaker 3: really difficult, right, and I think when we look to
- 24:44Speaker 3: scale this up, as I said before, with the aging
- 24:47Speaker 3: population that we're seeing, we need tools like.
- 24:50Speaker 2: This to do it right right right, especially as things
- 24:54Speaker 2: like long term care at home become standard and pharmacists
- 24:59Speaker 2: get more involved with that, because you know, there is
- 25:04Speaker 2: something when you have everybody at one place, you have
- 25:08Speaker 2: a facility in your system, and you're working with that
- 25:10Speaker 2: one facility. I wouldn't say it's easier, but it's you know, compact.
- 25:15Speaker 2: You have all that information there, you can flag it
- 25:17Speaker 2: by facility and look to see your patients there. But
- 25:19Speaker 2: when you suddenly have all these diffuse locations with individual patients,
- 25:26Speaker 2: having all that data in one place and having a
- 25:28Speaker 2: prioritize for you, like you're saying, it's going to be
- 25:30Speaker 2: a huge time saver. I mean, you wouldn't be able
- 25:32Speaker 2: to do it manually, probably like at a certain point
- 25:34Speaker 2: if you scaled up as a pharmacist. I don't see
- 25:37Speaker 2: how to be able to handle all that without hiring.
- 25:41Speaker 3: I absolutely agree with what you're saying. So, you know,
- 25:44Speaker 3: let's let's fast forward and think of the environment that
- 25:47Speaker 3: we're headed in. You know, my parents aged at home
- 25:53Speaker 3: because they didn't want to go into a nursing home.
- 25:55Speaker 3: We were fortunate we could get them the care they
- 25:57Speaker 3: needed so they could do that. Right, I really don't
- 26:00Speaker 3: want to go into a nursing home when I is
- 26:03Speaker 3: right there, you go. So what you're seeing is a
- 26:07Speaker 3: real shift in the population where when the nursing home
- 26:12Speaker 3: industry came about, and there's a role that they play
- 26:15Speaker 3: which is critical, right, But now you see more and
- 26:20Speaker 3: more people saying, I really want to age at home
- 26:22Speaker 3: and I need tools to do it. The tools that
- 26:26Speaker 3: have been available are really clinical tools, right. They've been
- 26:31Speaker 3: physical therapists that will go to the home. There'll be
- 26:34Speaker 3: physicians and nurses that will go to the home. But
- 26:37Speaker 3: who's doing this kind of work in a scaled way? Right?
- 26:42Speaker 3: We have heard a pharmacist going into a home that's
- 26:45Speaker 3: certainly been there, but again not with tools like this.
- 26:49Speaker 3: So I think that as the environment changes and more
- 26:53Speaker 3: and more people want to stay at home, to the
- 26:56Speaker 3: point that you're making, that's a pretty complex environment and
- 27:00Speaker 3: it's a very diffuse environment, right people are everywhere. How
- 27:03Speaker 3: do you effectively manage that without tools? I think it's
- 27:07Speaker 3: very difficult. And what we've done is we've created these
- 27:11Speaker 3: tools that we think makes it easier and not only
- 27:16Speaker 3: easier for us, which allows us to scale, but it
- 27:20Speaker 3: provides that standard of care for the patient also, So
- 27:24Speaker 3: we think it's definitely needed in the marketplace.
- 27:27Speaker 2: Right right, Well, that was one of the questions was
- 27:29Speaker 2: how you see medication therapy management evolving in long term
- 27:33Speaker 2: care pharmacy, And I think that's one of the real
- 27:36Speaker 2: areas is this long term care at home or you know, alternative,
- 27:41Speaker 2: very different setting. It doesn't necessarily have to be an
- 27:44Speaker 2: individual it can be a group home or such. But
- 27:47Speaker 2: I think long term care and the technology you're talking
- 27:53Speaker 2: about is going to have a big impact because people
- 27:56Speaker 2: will be able to do this because the pharmacies and
- 27:58Speaker 2: will be able to provide the care. And also, I
- 28:01Speaker 2: think we've been touching on this a lot. Connect with
- 28:03Speaker 2: other wider healthcare landscape providers and such. Yeah, look, I agree.
- 28:12Speaker 3: I think of it as the effective coordination of care
- 28:17Speaker 3: without a holistic partner like ours, who is watching that
- 28:22Speaker 3: patient and has the data of when they're in a
- 28:25Speaker 3: skilled nursing facility, is watching that patient as they transition
- 28:30Speaker 3: through the different stages and different places that they go
- 28:34Speaker 3: and rotating through them. We have visibility.
- 28:38Speaker 2: Right.
- 28:39Speaker 3: There are many patients that we have today that we
- 28:41Speaker 3: watch that are at home, They go into a hospital,
- 28:45Speaker 3: they go into a nursing home for a period of time,
- 28:48Speaker 3: and then they go back home again. As they're going
- 28:52Speaker 3: through that. In certain markets, some of those patients are
- 28:55Speaker 3: ours throughout that whole transition. That gives us the ability
- 29:00Speaker 3: to really be an effective advocate and partner for that patient,
- 29:04Speaker 3: and it gives data and information to the pair previously
- 29:09Speaker 3: was getting retrospective data ninety days late in terms of
- 29:13Speaker 3: claims and then trying to sort it out right. That
- 29:18Speaker 3: doesn't work because if it's ninety days later, three months later,
- 29:23Speaker 3: the amount of actions you can take are very delayed.
- 29:26Speaker 3: Right With patients in you know, with a lot of
- 29:30Speaker 3: core mobidities that are in that high risk population, actions
- 29:35Speaker 3: need to be taken faster to get the best outcome.
- 29:39Speaker 3: And I think us straddling across all these different points
- 29:44Speaker 3: in that post acute segment positions us as a great
- 29:48Speaker 3: partner for a lot of these pairs because now we
- 29:51Speaker 3: can effectively, in partnership with them manage that patient from
- 29:55Speaker 3: a med management standpoint.
- 29:57Speaker 2: Yeah, I mean that an area I'd like to actually
- 30:00Speaker 2: hear a little bit more about because the payer side
- 30:03Speaker 2: of it, they I think that that's where pharmacy being
- 30:06Speaker 2: able to be so connected is important. Like you're saying
- 30:10Speaker 2: you don't want to wait three months, they will they
- 30:14Speaker 2: You know, medication therapy management works on a monthly basis
- 30:17Speaker 2: basically for most or two weeks depending on any sort
- 30:21Speaker 2: of med changes. So this idea of being able to
- 30:25Speaker 2: continue the loop on a more regular basis has to
- 30:28Speaker 2: be a big win for payers. Also.
- 30:31Speaker 3: Yeah, look, I think the industry really started in a
- 30:34Speaker 3: couple of different ways right working with payers. The standard
- 30:38Speaker 3: programs are the medication adherence programs, the part d MTM programs,
- 30:45Speaker 3: the STARS related initiatives. Those are just basic core programs
- 30:49Speaker 3: and those are the basic offerings that a lot of
- 30:51Speaker 3: folks have, but those are back end analytical based right.
- 30:57Speaker 3: There are organizations out there that have existed that will
- 31:00Speaker 3: take a lot of that data on the back end,
- 31:02Speaker 3: they'll churn it and they'll give it to the healthcare
- 31:05Speaker 3: the health plan. What's a health plan going to do
- 31:08Speaker 3: with at that point? Now, the health plan will in
- 31:11Speaker 3: many cases hire somebody to say, okay, make some phone
- 31:15Speaker 3: calls and try to get some shifts in therapy. Call
- 31:18Speaker 3: the provider, call the patient and shift. How many times
- 31:22Speaker 3: do you pick up a call when from a number
- 31:24Speaker 3: that you don't recognize? Right, Oh, well we'll go one
- 31:28Speaker 3: step better. We'll send them an email, our letter. Well,
- 31:30Speaker 3: that'll get it done. Right. So the best way to
- 31:35Speaker 3: really do this is when you have that direct relationship
- 31:38Speaker 3: with a patient and you are their pharmacy of record
- 31:41Speaker 3: and you are engaging with them as it is anyway.
- 31:44Speaker 3: So now all that information is coming in, we're doing
- 31:48Speaker 3: the analytics back in, and instead of that health plan
- 31:52Speaker 3: saying let me hire a third person to go out
- 31:54Speaker 3: and really engage with that patient, we have those tools also,
- 31:58Speaker 3: so we are that singular partner. And then outside of
- 32:02Speaker 3: the core programs, we have other programs, other specific clinical
- 32:06Speaker 3: programs that we can layer on top, such as there
- 32:10Speaker 3: is opiate therapy support program folks that need it. There
- 32:14Speaker 3: may be review of social determinants of help that may
- 32:18Speaker 3: be preventing them from getting the right type of outcome.
- 32:21Speaker 3: Polypharmacy is a real issue, right, Folks are going everywhere
- 32:25Speaker 3: looking for the lowest price. It's cost go one day,
- 32:28Speaker 3: it's CBS another day, somewhere else. Right, based on the
- 32:32Speaker 3: medications and the price they can get for them, there's room.
- 32:36Speaker 3: Retard Arthritis is a real issue, and there's specific programs
- 32:40Speaker 3: we have around that and care there. So you take
- 32:43Speaker 3: the core programs, then you layer on these clinical specific
- 32:47Speaker 3: programs and you've really got a holistic partner like us
- 32:52Speaker 3: that can help manage that care for that patient.
- 32:55Speaker 2: Yeah, it's a robust clinical profile. I mean you really can.
- 33:00Speaker 2: And the social determines of health is Pharmacy is really
- 33:04Speaker 2: going to be front and center with that movement because
- 33:09Speaker 2: many especially we look at this country and the rural areas,
- 33:13Speaker 2: the pharmacies their main healthcare contact on a regular basis.
- 33:18Speaker 2: So the pharmacist being able to understand what might be
- 33:22Speaker 2: preventing a patient from staying adherent and is key to
- 33:27Speaker 2: this healthcare cost.
- 33:28Speaker 3: You don't know how many patients we've talked to in
- 33:30Speaker 3: rural settings where we talked to them about compliance and adherence,
- 33:34Speaker 3: and after engagement, we find out, look, I'm just too old.
- 33:39Speaker 3: I just can't get to the pharmacy that's so far
- 33:41Speaker 3: away from me, and that's why I haven't been taking
- 33:44Speaker 3: my meds. And you know, we say, well, look we'll
- 33:48Speaker 3: deliver it to your home for free. And it's a
- 33:50Speaker 3: huge relief, right right. And there are people out there
- 33:53Speaker 3: that can deliver at home for free. But again they're
- 33:56Speaker 3: checking the box, oh you need drugs, which rug okay
- 34:00Speaker 3: about it. They aren't partners in that care, in that
- 34:03Speaker 3: care management like we are.
- 34:06Speaker 4: Right and I think that, I mean, one of the
- 34:10Speaker 4: final questions was, you know, when we've talked about the
- 34:13Speaker 4: different audiences that that you address.
- 34:16Speaker 2: And work with, and you know, I don't know, actually,
- 34:21Speaker 2: I mean I can ask this question. I feel like
- 34:23Speaker 2: you've really covered it. But you know, this healthcare journey
- 34:26Speaker 2: and the various ways that you support the different audiences
- 34:30Speaker 2: in this or the people you know you have. We
- 34:34Speaker 2: have patients, we have pharmacists, we have skilled nursing staff, caregivers.
- 34:41Speaker 2: All these people are part of this this healthcare journey
- 34:45Speaker 2: and it really feels like from what you're how you're
- 34:48Speaker 2: describing all the services and you've thought about all these
- 34:52Speaker 2: people and how to make them connected.
- 34:55Speaker 3: Yeah. Look, I don't think that the concept is is
- 35:00Speaker 3: novel idea that we just came up with. A lot
- 35:03Speaker 3: of people talk about doing things like this, and if
- 35:06Speaker 3: you go into certain markets, they will be small entities
- 35:10Speaker 3: that are doing something like this, right, and I think
- 35:13Speaker 3: that's great. But with the population that we're talking about,
- 35:17Speaker 3: especially the aging population, there needs to be mechanism to
- 35:21Speaker 3: really scale this across the country because if you can
- 35:25Speaker 3: effectively scale it, you can really take care of the
- 35:28Speaker 3: population that's coming. These smaller players with more volume and
- 35:33Speaker 3: without the tools I'm talking about will not be able
- 35:36Speaker 3: to scale. So we have put those things together. We
- 35:41Speaker 3: have done what I described, which is go out and
- 35:43Speaker 3: say this is a capability we're lacking. Let us acquire
- 35:47Speaker 3: that capability or build it in house so we can
- 35:50Speaker 3: scale it. And it's critical a lot of these positions
- 35:56Speaker 3: providers that we speak to as we are at advocates
- 36:00Speaker 3: for that patient, they basically give us a call later
- 36:03Speaker 3: and say, look, I got a couple more patients. You know,
- 36:06Speaker 3: I can see that they're struggling. They could really benefit
- 36:09Speaker 3: from what you're doing. So, you know, we've got providers
- 36:12Speaker 3: that want to send us patients. We've got hospital systems
- 36:15Speaker 3: that say we're discharging patients and they're coming right back in.
- 36:19Speaker 3: We know who they are, and we know it's a
- 36:21Speaker 3: med management issue. Can you help us? So there's a workstream, right,
- 36:26Speaker 3: those providers given us. And then there's always the payer
- 36:29Speaker 3: who's sitting there again looking at retrospective data. But they're
- 36:33Speaker 3: sitting there looking at it and saying, hey, this population
- 36:36Speaker 3: is really really not adherent, is not on the right meds,
- 36:40Speaker 3: their therapy is all wrong, and we see it in
- 36:43Speaker 3: the cost. So I think there's a lot of different
- 36:47Speaker 3: constituencies that are starting to see the value of what
- 36:51Speaker 3: we can provide. And I don't even mention the patient
- 36:53Speaker 3: and their family yet, right, who see the greatest value
- 36:57Speaker 3: in all of this. So we're very, very excited about
- 37:01Speaker 3: the organization that we're putting together, the capabilities that we have,
- 37:05Speaker 3: and our ability to scale this. We are one of
- 37:08Speaker 3: the largest long term care institutional pharmacies in the country.
- 37:12Speaker 3: That was our core and now with these additive services,
- 37:16Speaker 3: our goal is to be not just viewed as as
- 37:20Speaker 3: institutional based long term care, but post acute based long
- 37:25Speaker 3: term care because as you and I said, those patients
- 37:28Speaker 3: are everywhere. Somebody's got to coordinate all of that.
- 37:32Speaker 2: That's amazing, And that's talking about the future of long
- 37:35Speaker 2: term care, right, I mean, we're our syptem Bractober issue
- 37:39Speaker 2: we're w working on now. That's the theme in general
- 37:42Speaker 2: is you know, what are these trends in long term
- 37:44Speaker 2: care pharmacy and what technology solutions are coming out to
- 37:48Speaker 2: support those changes and the innovation that's coming forward, And
- 37:52Speaker 2: what you're talking about is that innovation of pulling all
- 37:54Speaker 2: these different pieces together and making a holistic approach to it.
- 37:58Speaker 3: Absolutely, that's what we're uh, that's what we're attempting to do,
- 38:01Speaker 3: and I think we are in a very good position
- 38:04Speaker 3: to scale this.
- 38:05Speaker 2: M Well great, I think we uh covered a lot.
- 38:09Speaker 2: Actually I actually did thank you for sharing all this.
- 38:14Speaker 2: Do you have anything else you want to add before
- 38:16Speaker 2: we Well?
- 38:18Speaker 3: Yeah, I mean I think you just need to keep
- 38:20Speaker 3: your fingers crossed and pray that the Phillies can turn
- 38:23Speaker 3: this around and win win again. Right, It's been too long,
- 38:28Speaker 3: and uh, don't forget about the sixers. We've got a
- 38:30Speaker 3: lot going on there too. Other than that, I think
- 38:32Speaker 3: things are good, good, everything's.
- 38:34Speaker 2: Good if you can only manage the outcomes on the
- 38:38Speaker 2: on the Phillies.
- 38:40Speaker 3: We haven't developed an algorithm for that yet. You did.
- 38:45Speaker 2: I think that very people be very excited for that.
- 38:48Speaker 2: Leeds in Philadelphia in the one one area code